Shortening the timeline for clinical drug developments

Building international collaborations and the WINTHER trial

GFI is crucial for AML1-ETO induced acute myeloid leukemia

Mouse models and proteomics tackling acute lymphoblastic leukaemia

BRCA carrier status as a prognostic factor for prostate cancer

ASCO 2012 Drug Development Research Professorship

Effects of panitumumab against oesophageal-gastro cancer and carcinomas

Routine molecular testing of non-small cell lung cancers in community settings

Prognostic biomarkers and next generation genomic sequencing

Primary and secondary resistance in colorectal cancer

Highlights and goals of IMPAKT 2012

Molecularly characterising triple negative breast cancer